Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial

BACKGROUND: Neoadjuvant chemotherapy is a standard of care for patients with adenocarcinoma of the esophagus and stomach in Europe, but still only 20–40 % respond to therapy and the critical issue; how to treat nonresponding patients is still unclear. So far, there is no randomized trial evaluating...

Descripción completa

Detalles Bibliográficos
Autores principales: Blank, Susanne, Knebel, Phillip, Haag, Georg-Martin, Bruckner, Thomas, Klaiber, Ulla, Burian, Maria, Schaible, Anja, Sisic, Leila, Schmidt, Thomas, Diener, Markus K., Ott, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153833/
https://www.ncbi.nlm.nih.gov/pubmed/27965838
http://dx.doi.org/10.1186/s40814-016-0059-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153833/
https://www.ncbi.nlm.nih.gov/pubmed/27965838
http://dx.doi.org/10.1186/s40814-016-0059-x

Ejemplares similares